Latham Group Shares Draw Conflicting Signals From Major Players

The investment landscape for Latham Group, Inc. presents a complex picture as significant institutional buying activity clashes with a persistent bearish stance from a major investment bank. This divergence of opinion is creating a notable dilemma for market participants evaluating the swimming pool manufacturer’s prospects.

Robust Quarterly Performance

Latham Group’s operational fundamentals demonstrated strength in its second quarter 2025 financial results. The company reported a 7.8 percent increase in revenue alongside a 15.7 percent rise in adjusted EBITDA. Chief Executive Officer Scott M. Rajeski attributed this positive performance to the company’s diversified product portfolio, strong market position, and successful acquisition strategy. Management subsequently reaffirmed its full-year 2025 guidance.

Institutional Investors Expand Positions

Contrasting with the cautious analyst view, institutional investors have been actively accumulating positions in Latham. AYAL Capital Advisors Ltd. established a new holding during the first quarter of 2025, acquiring 567,900 shares valued at $3.65 million. This investment represents 0.49 percent of the company’s outstanding shares and ranks as the 26th largest position in AYAL’s portfolio. They are not alone in their interest; other prominent institutions including BNP Paribas Financial Markets and the New York State Common Retirement Fund have either established new positions or increased their existing stakes in the company.

Should investors sell immediately? Or is it worth buying Latham?

Goldman Sachs Maintains Cautious Stance

Despite this institutional accumulation and strong quarterly results, Goldman Sachs maintains its skeptical outlook. The investment bank recently increased its price target from $4.00 to $4.50 per share but notably preserved its “Sell” recommendation. This position stands in sharp contrast to the broader analyst consensus, which currently rates the stock as a “Moderate Buy” with an average price target of $7.95.

The conflicting perspectives between bullish institutional investors and Goldman Sachs’s continued skepticism have created uncertainty in the market. Investors now face the decision of whether to align with the long-term confidence demonstrated by major funds or heed the investment bank’s more cautious short-term assessment.